These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 21972004)
1. SNP rs2470152 in CYP19 is correlated to aromatase activity in Chinese polycystic ovary syndrome patients. Zhang XL; Zhang CW; Xu P; Liang FJ; Che YN; Xia YJ; Cao YX; Wu XK; Wang WJ; Yi L; Gao Q; Wang Y Mol Med Rep; 2012 Jan; 5(1):245-9. PubMed ID: 21972004 [TBL] [Abstract][Full Text] [Related]
2. Association between CYP19 gene SNP rs2414096 polymorphism and polycystic ovary syndrome in Chinese women. Jin JL; Sun J; Ge HJ; Cao YX; Wu XK; Liang FJ; Sun HX; Ke L; Yi L; Wu ZW; Wang Y BMC Med Genet; 2009 Dec; 10():139. PubMed ID: 20015405 [TBL] [Abstract][Full Text] [Related]
3. Impact of rs2414096 polymorphism of CYP19 gene on susceptibility of polycystic ovary syndrome and hyperandrogenism in Kashmiri women. Ashraf S; Rasool SUA; Nabi M; Ganie MA; Masoodi SR; Amin S Sci Rep; 2021 Jun; 11(1):12942. PubMed ID: 34155264 [TBL] [Abstract][Full Text] [Related]
4. The synergistic effect of sex hormone-binding globulin and aromatase genes on polycystic ovary syndrome phenotype. Xita N; Georgiou I; Lazaros L; Psofaki V; Kolios G; Tsatsoulis A Eur J Endocrinol; 2008 Jun; 158(6):861-5. PubMed ID: 18505907 [TBL] [Abstract][Full Text] [Related]
5. Association of the Munawar Lone N; Babar S; Sultan S; Malik S; Nazeer K; Riaz S Gynecol Endocrinol; 2021 May; 37(5):456-461. PubMed ID: 32960117 [TBL] [Abstract][Full Text] [Related]
6. The (TTTA)n polymorphism in intron 4 of CYP19 and the polycystic ovary syndrome risk in a Chinese population. Xu P; Zhang XL; Xie GB; Zhang CW; Shen SM; Zhang XX; Cao YX; Wang WJ; Che YN; Xia YJ; Wu XK; Yi L; Gao Q; Wang Y Mol Biol Rep; 2013 Aug; 40(8):5041-7. PubMed ID: 23661022 [TBL] [Abstract][Full Text] [Related]
7. Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism. Gharani N; Waterworth DM; Batty S; White D; Gilling-Smith C; Conway GS; McCarthy M; Franks S; Williamson R Hum Mol Genet; 1997 Mar; 6(3):397-402. PubMed ID: 9147642 [TBL] [Abstract][Full Text] [Related]
8. Association of CYP17A1 gene -34T/C polymorphism with polycystic ovary syndrome in Han Chinese population. Li L; Gu ZP; Bo QM; Wang D; Yang XS; Cai GH Gynecol Endocrinol; 2015 Jan; 31(1):40-3. PubMed ID: 25208301 [TBL] [Abstract][Full Text] [Related]
9. Association between polymorphisms of the CYP11A1 gene and polycystic ovary syndrome in Chinese women. Zhang CW; Zhang XL; Xia YJ; Cao YX; Wang WJ; Xu P; Che YN; Wu XK; Yi L; Gao Q; Wang Y Mol Biol Rep; 2012 Aug; 39(8):8379-85. PubMed ID: 22699877 [TBL] [Abstract][Full Text] [Related]
10. Aromatase gene polymorphism does not influence clinical phenotype and response to oral contraceptive pills in polycystic ovary syndrome women. Maier PS; Spritzer PM Gynecol Obstet Invest; 2012; 74(2):136-42. PubMed ID: 22889864 [TBL] [Abstract][Full Text] [Related]
11. The relationship between the CYP19 alleles rs727479A/C, rs700518A/G, and rs700519C/T and pregnancy outcome after assisted reproductive technology in patients with polycystic ovary syndrome in a Chinese population: A population-based study. Dou Q; Tan L; Ma LY; Sun YP Kaohsiung J Med Sci; 2017 Nov; 33(11):558-566. PubMed ID: 29050673 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the association between the CYP19 Tetranucleotide (TTTA)n polymorphism and polycystic ovarian syndrome(PCOS) in Han Chinese women. Hao CF; Zhang N; Qu Q; Wang X; Gu HF; Chen ZJ Neuro Endocrinol Lett; 2010; 31(3):370-4. PubMed ID: 20588246 [TBL] [Abstract][Full Text] [Related]
13. Association between ACE gene I/D polymorphisms and hyperandrogenism in women with polycystic ovary syndrome (PCOS) and controls. Sun J; Fan H; Che Y; Cao Y; Wu X; Sun HX; Liang F; Yi L; Wang Y BMC Med Genet; 2009 Jul; 10():64. PubMed ID: 19602270 [TBL] [Abstract][Full Text] [Related]
15. Effects of apoC1 genotypes on the hormonal levels, metabolic profile and PAF-AH activity in Chinese women with polycystic ovary syndrome. Zhang R; Liu Q; Liu H; Bai H; Zhang Y; Guan L; Fan P Lipids Health Dis; 2018 Apr; 17(1):77. PubMed ID: 29636060 [TBL] [Abstract][Full Text] [Related]
16. Delineating the role of single-nucleotide polymorphism of CYP19 gene on aromatase activity in South Indian women with polycystic ovary syndrome. Hegde P; Shetty SS; Shetty PK; Manjeera L; Shetty DP; Kumari S J Genet Eng Biotechnol; 2023 Aug; 21(1):87. PubMed ID: 37603197 [TBL] [Abstract][Full Text] [Related]
17. Association of aromatase (CYP 19) gene variation with features of hyperandrogenism in two populations of young women. Petry CJ; Ong KK; Michelmore KF; Artigas S; Wingate DL; Balen AH; de Zegher F; Ibáñez L; Dunger DB Hum Reprod; 2005 Jul; 20(7):1837-43. PubMed ID: 15802318 [TBL] [Abstract][Full Text] [Related]
18. Association Study between Polycystic Ovarian Syndrome and the Susceptibility Genes Polymorphisms in Hui Chinese Women. Ha L; Shi Y; Zhao J; Li T; Chen ZJ PLoS One; 2015; 10(5):e0126505. PubMed ID: 25978310 [TBL] [Abstract][Full Text] [Related]
19. CYP19 gene expression in subcutaneous adipose tissue is associated with blood pressure in women with polycystic ovary syndrome. Lecke SB; Morsch DM; Spritzer PM Steroids; 2011 Nov; 76(12):1383-8. PubMed ID: 21807013 [TBL] [Abstract][Full Text] [Related]
20. Association of SOD2 A16V and PON2 S311C polymorphisms with polycystic ovary syndrome in Chinese women. Liu Q; Liu H; Bai H; Huang W; Zhang R; Tan J; Guan L; Fan P J Endocrinol Invest; 2019 Aug; 42(8):909-921. PubMed ID: 30607774 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]